The Dana-Farber Cancer Institute at Londonderry — Londonderry, New Hampshire

The Dana-Farber Cancer Institute at Londonderry is a clinical research site located in Londonderry, New Hampshire, United States 03053.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

The Dana-Farber Cancer Institute at Londonderry has participated in 23 clinical trials with 15 currently active.

Therapeutic areas: Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Londonderry

Browse all research sites in New Hampshire · View every site in Londonderry

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Dana-Farber Cancer Institute at Londonderry?

The Dana-Farber Cancer Institute at Londonderry has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Dana-Farber Cancer Institute at Londonderry conducted?

The Dana-Farber Cancer Institute at Londonderry has 23 clinical trials on record, with 15 currently active. Their work covers Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative.

Is The Dana-Farber Cancer Institute at Londonderry accredited by Crixeo Clinical Trials?

The Dana-Farber Cancer Institute at Londonderry has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Dana-Farber Cancer Institute at Londonderry?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.